When medicines change our behaviour – New podcast out now

Research / 02 May 2024

Adverse effects to medicines are not just physical in nature, but can manifest as behavioural side-effects too. How do we diagnose and treat these complex ADRs?


Drug-induced impulse control disorders have the potential to negatively impact overall quality of life, but are especially hard to identify, diagnose, and treat. In the latest Drug Safety Matters podcast, Michele Fusaroli of the University of Bologna describes which types of medicines are most likely to cause these impulsive behaviours, and how listening to patient stories can be a huge help in their detection and treatment.

Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:

Related Articles

AI meets psychedelic storytelling: What online forums can teach pharmacovigilance

Revisiting the role of medication utilisation evaluations to assess adherence to risk minimisation measures

Beyond numbers, quality in ADR reporting – New podcast episode

You may also like

Beyond numbers, quality in ADR reporting – New podcast episode

Spontaneous adverse event reports pose significant challenges to pharmacovigilance scientists. How may we turn them into opportunities that benefit our pharmacovigilance systems?

04 June 2025

AI meets psychedelic storytelling: What online forums can teach pharmacovigilance

Online psychedelic forums hold untapped safety data. AI analysis of user narratives could help pharmacovigilance systems detect risks missed by traditional reporting.

13 November 2025

Revisiting the role of medication utilisation evaluations to assess adherence to risk minimisation measures

MUEs are typically used to improve the safety of drugs, however, may they also have a role in measuring the adherence to risk minimisation measures?

06 August 2025